Phelan K, McDermid HE. The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome). Mol Syndromol. 2011;2(3–5):186–201.

Article  PubMed  PubMed Central  Google Scholar 

Kolevzon A, Angarita B, Bush L, Wang AT, Frank Y, Yang A, et al. Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring. J Neurodevelop Disord. 2014;6(1):39.

Article  Google Scholar 

Dhar SU, Del Gaudio D, German JR, Peters SU, Ou Z, Bader PI, et al. 22q13.3 deletion syndrome: Clinical and molecular analysis using array CGH. Am J Med Genet A. 2010;152(3):573–81.

Article  Google Scholar 

Soorya L, Kolevzon A, Zweifach J, Lim T, Dobry Y, Schwartz L, et al. Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency. Mol Autism. 2013;4(1):18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Rubeis S, Siper PM, Durkin A, Weissman J, Muratet F, Halpern D, et al. Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations. Mol Autism. 2018;9(1):31.

Article  PubMed  PubMed Central  Google Scholar 

Figura MG, Coppola A, Bottitta M, Calabrese G, Grillo L, Luciano D, et al. Seizures and EEG pattern in the 22q13.3 deletion syndrome: Clinical report of six Italian case. Seizure. 2014;23(9):774–9.

Article  PubMed  Google Scholar 

Xu N, Lv H, Yang T, Du X, Sun Y, Xiao B, et al. A 29 Mainland Chinese cohort of patients with Phelan-McDermid syndrome: genotype-phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes. Orphanet J Rare Dis. 2020;15(1):335.

Article  PubMed  PubMed Central  Google Scholar 

Holder JL, Quach MM. The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK 3 loss-of-function mutations. Epilepsia. 2016;57(10):1651–9.

Article  PubMed  PubMed Central  Google Scholar 

Burdeus-Olavarrieta M, San José-Cáceres A, García-Alcón A, González-Peñas J, Hernández-Jusdado P, Parellada-Redondo M. Characterisation of the clinical phenotype in Phelan-McDermid syndrome. J Neurodev Disord. 2021;13(1):26.

Article  PubMed  PubMed Central  Google Scholar 

Jain L, Oberman LM, Beamer L, Cascio L, May M, Srikanth S, et al. Genetic and metabolic profiling of individuals with Phelan-McDermid syndrome presenting with seizures. Clin Genet. 2022;101(1):87–100.

Article  CAS  PubMed  Google Scholar 

Frank Y. The Neurological Manifestations of Phelan-McDermid Syndrome. Pediatr Neurol. 2021;122:59–64.

Article  PubMed  Google Scholar 

Bonaglia MC, Giorda R, Beri S, De Agostini C, Novara F, Fichera M, et al. Molecular Mechanisms Generating and Stabilizing Terminal 22q13 Deletions in 44 Subjects with Phelan/McDermid Syndrome. PLoS Genet. 2011Jul;7(7): e1002173.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aldinger KA, Kogan J, Kimonis V, Fernandez B, Horn D, Klopocki E, et al. Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion. Am J Med Genet A. 2013;161A(1):131–6.

Article  PubMed  Google Scholar 

Philippe A, Boddaert N, Vaivre-Douret L, Robel L, Danon-Boileau L, Malan V, et al. Neurobehavioral Profile and Brain Imaging Study of the 22q13.3 Deletion Syndrome in Childhood. Pediatrics. 2008;122(2):e376-82.

Article  PubMed  Google Scholar 

Tabet AC, Rolland T, Ducloy M, Lévy J, Buratti J, Mathieu A, et al. A framework to identify contributing genes in patients with Phelan-McDermid syndrome. NPJ Genom Med. 2017;2:32.

Article  PubMed  PubMed Central  Google Scholar 

Rollins JD, Sarasua SM, Phelan K, DuPont BR, Rogers RC, Collins JS. Growth in Phelan–McDermid syndrome. Am J Med Genet A. 2011;155(9):2324–6.

Article  Google Scholar 

Sarasua SM, DeLuca JM, Rogers C, Phelan K, Rennert L, Powder KE, et al. Head Size in Phelan–McDermid Syndrome: A Literature Review and Pooled Analysis of 198 Patients Identifies Candidate Genes on 22q13. Genes. 2023;14(3):540.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nesslinger NJ, Gorski JL, Kurczynski TW, Shapira SK, Siegel-Bartelt J, Dumanski JP, et al. Clinical, cytogenetic, and molecular characterization of seven patients with deletions of chromosome 22q13.3. Am J Hum Genet. 1994;54(3):464–72.

CAS  PubMed  PubMed Central  Google Scholar 

Cusmano‐Ozog K, Manning MA, Hoyme HE. 22q13.3 deletion syndrome: A recognizable malformation syndrome associated with marked speech and language delay. Am J Med Genet C Semin Med Genet. 2007;145(4):393–8.

Article  Google Scholar 

Sarasua SM, Boccuto L, Sharp JL, Dwivedi A, Chen CF, Rollins JD, et al. Clinical and genomic evaluation of 201 patients with Phelan–McDermid syndrome. Hum Genet. 2014;133(7):847–59.

Article  CAS  PubMed  Google Scholar 

Betancur C, Buxbaum JD. SHANK3 haploinsufficiency: a “common” but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders. Mol Autism. 2013;4(1):17.

Article  CAS  PubMed  Google Scholar 

Samogy-Costa CI, Varella-Branco E, Monfardini F, Ferraz H, Fock RA, Barbosa RHA, et al. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case. J Neurodev Disord. 2019;11(1):13.

Article  PubMed  Google Scholar 

Phelan-McDermid Syndrome - Symptoms, Causes, Treatment | NORD. https://rarediseases.org/rare-diseases/phelan-mcdermid-syndrome/. Accessed 15 Jan 2024.

PMSF By The Numbers. Phelan-McDermid Syndrome Foundation. https://pmsf.org/pmsf-by-the-numbers/ Accessed 15 Jan 2024.

Bonaglia MC, Giorda R, Borgatti R, Felisari G, Gagliardi C, Selicorni A, Zuffardi O. Disruption of the ProSAP2 Gene in a t(12;22)(q24.1;q13.3) Is Associated with the 22q13.3 Deletion Syndrome. Am J Hum Genet. 2001;69(2):261–8.

Article  CAS  PubMed  Google Scholar 

Verpelli C, Dvoretskova E, Vicidomini C, Rossi F, Chiappalone M, Schoen M, et al. Importance of Shank3 Protein in Regulating Metabotropic Glutamate Receptor 5 (mGluR5) Expression and Signaling at Synapses. J Biol Chem. 2011;286(40):34839–50.

Article  CAS  PubMed  Google Scholar 

Oberman LM, Boccuto L, Cascio L, Sarasua S, Kaufmann WE. Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations. Orphanet J Rare Dis. 2015;10(1):105.

Article  PubMed  Google Scholar 

Sarasua SM, Dwivedi A, Boccuto L, Rollins JD, Chen CF, Rogers RC, et al. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome). J Med Genet. 2011;48(11):761–6.

Article  CAS  PubMed  Google Scholar 

Sarasua SM, Dwivedi A, Boccuto L, Chen CF, Sharp JL, Rollins JD, et al. 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan–McDermid syndrome. Genet Med. 2014;16(4):318–28.

Article  CAS  PubMed  Google Scholar 

Levy T, Foss-Feig JH, Betancur C, Siper PM, Trelles-Thorne MDP, Halpern D, et al. Strong evidence for genotype–phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium. Hum Mol Genet. 2022;31(4):625–37.

Article  CAS  PubMed  Google Scholar 

Smith MS, Sarasua SM, Rogers C, Phelan K, Boccuto L. Lymphedema is associated with CELSR1 in Phelan-McDermid syndrome. Clin Genet. 2023;104(4):472–8.

Article  CAS  PubMed  Google Scholar 

Ricciardello A, Tomaiuolo P, Persico AM. Genotype–phenotype correlation in Phelan-McDermid syndrome: A comprehensive review of chromosome 22q13 deleted genes. Am J Med Genet A. 2021;185(7):2211–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Phelan K, Boccuto L, Powell CM, Boeckers TM, van Ravenswaaij-Arts C, Rogers RC, et al. Phelan-McDermid syndrome: a classification system after 30 years of experience. Orphanet J Rare Dis. 2022;17(1):27.

Article  PubMed